- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Relevium Technologies: Global Brands for the Nutraceutical and Wellness Markets
Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF;FWB:6BX) has launched its campaign on the Investing News Network’s cannabis channel.
Relevium Technologies (TSXV:RLV,OTC:RLLVF;FWB:6BX) has launched its campaign on the Investing News Network’s cannabis channel.
Relevium Technologies is developing a portfolio of brands, products and technologies in the health and wellness market. The company has assets in the United States and the United Kingdom with plans to expand into international markets including Canada and Latin America. The company is developing four brands which are offered through its two subsidiaries: BioGanix and Biocannabix. BioGanix is the parent company for a variety of weight-loss, health, beauty and fitness supplements. Together the brands under the BioGanix label generate over $1 million in revenue per quarter.
Biocannabix aims to serve the pediatric and adult markets with nutraceutical and pharmaceutical cannabis-based products available in the United States and Europe. Relevium has launched LeefyLyfe, a hemp-based product line, to consumers in the UK under its Biocannabix brand. Biocannabix has secured a 93,000-square-foot organic cultivation and processing facility in Montreal, Quebec. Once complete, the facility is expected to be home to Relevium’s research and development facilities.
Relevium Technologies’ company highlights include the following:
- Global cannabis market to surpass $31 billion by 2021.
- In 2017, the global wellness market reached $4.2 trillion.
- Global nutraceutical market to reach US$578.23 billion by 2025.
- Vast distribution network through industry giants like Walmart and Amazon.
- Building out 93,000-square-foot cannabis cultivation and processing facility in Montreal, Quebec.
- BioGanix generates approximately $1 million in revenue per quarter.
- 47 SKUs developed for BioGanix to date.
- Acquiring Cannakids’s IP, a leader in medical cannabis patient research and pediatric and adult consumer product development.
- Pending Sleipnir acquisition will initially bring in US$500,000 to Relevium’s topline revenue.
- Partnership in place with HempCo Canada.
- International expansion plans for all brands.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â